DavidHoldenHenryIIIMD
Oncology • Philadelphia, PAHematologic Oncology
Clinical Professor of Medicine, University Pennsylvania
Dr. Henry is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
230 W Washington Sq
2nd Floor
Philadelphia, PA 19106Phone+1 215-829-6311Fax+1 215-829-6104- Is this information wrong?
Education & Training
University of Pennsylvania Health SystemFellowship, Hematology and Medical Oncology, 1978 - 1981- University of Pennsylvania Health SystemResidency, Internal Medicine, 1975 - 1977
Perelman School of Medicine at the University of PennsylvaniaClass of 1975
Certifications & Licensure
PA State Medical License 1976 - 2024
FL State Medical License 2015 - 2017- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2011-2014
- Philadelphia Magazine Castle Connolly, 2006, 2010-2014
- America's Top Doctors for Cancer Castle Connolly, 2010-2013
Clinical Trials
- Bortezomib, Ifosfamide, Carboplatin, and Etoposide, With or Without Rituximab, in Treating Patients With Relapsed or Refractory AIDS-Related Non-Hodgkin Lymphoma Start of enrollment: 2007 Nov 01
- Study of Blood and Tissue Samples From Patients With Aggressive Non-Hodgkin B-Cell Lymphoma or Hodgkin Lymphoma Start of enrollment: 2009 Aug 01
- Lenalidomide in Treating Patients With AIDS-Associated Kaposi's Sarcoma Start of enrollment: 2010 Aug 27
- Join now to see all
Publications & Presentations
PubMed
- 2 citationsBrentuximab vedotin with AVD for stage II-IV HIV-related Hodgkin lymphoma (AMC 085): phase 2 results from an open-label, single arm, multicentre phase 1/2 trial.Paul G Rubinstein, Page C Moore, Milan Bimali, Jeanette Y Lee, Michelle A Rudek, Amy Chadburn, Lee Ratner, David H Henry, Ethel Cesarman, Camille E DeMarco, Dominique ...> ;The Lancet. Haematology. 2023 Aug 1
- 1 citationsOpen-label, Phase 2 study of roxadustat for the treatment of anemia in patients receiving chemotherapy for non-myeloid malignancies.John Glaspy, Nashat Y Gabrail, Patricia Locantore-Ford, Tyson Lee, Katharina Modelska, Vivek Samal, David H Henry> ;American Journal of Hematology. 2023 May 1
- Safety and Tolerability of Carboplatin and Paclitaxel in Cancer Patients with HIV (AMC-078), an AIDS Malignancy Consortium (AMC) Study.Missak Haigentz, Page Moore, Milan Bimali, Joseph Sparano, Michelle Rudek, Lee Ratner, David Henry, Juan Ramos, John Deeken, Paul Rubinstein, Elizabeth Chiao, Timothy ...> ;The Oncologist. 2022 Aug 5
- Join now to see all
Abstracts/Posters
- Response-Adapted Therapy with Infusional EPOCH Chemotherapy Plus Rituximab in HIV-Associated, B-Cell Non-Hodgkin's LymphomaDavid H. Henry, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Safety and Efficacy of Brentuximab Vedotin in Combination with AVD in Stage II-IV HIV-Associated Classical Hodgkin Lymphoma: Results of the Phase 2 Study, AMC 085David H. Henry, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Efficacy and Safety of Ferric Carboxymaltose Injection in Reducing Anemia in Patients Receiving Chemotherapy for Non-Myeloid Malignancies: A Phase 3, Placebo-Controlle...David H. Henry, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Professional Memberships
- Member
- Member
Hospital Affiliations
Pennsylvania HospitalPhiladelphia, Pennsylvania
Bryn Mawr HospitalBryn Mawr, Pennsylvania
Hospital of the University of PennsylvaniaPhiladelphia, Pennsylvania
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
